Turn insights into action – fuel informed decisions, better outcomes and personalized care
Nearly half of genetic variants are classified differently by labs — and 25% of those disagreements can affect patient care. Resolve these challenges with access to full, reliable evidence.

Understand the genetic basis of diseases for more accurate diagnoses, risk assessments, and tailored treatment strategies.
Uncover insights on genetic markers, empowering your clinical decision-making abilities guiding you in every step of your patient care.
Discover critical information linking cancer variants to targeted therapies and clinical trials. Empower clinicians and diagnosticians to make faster, more informed decisions and accelerate personalized treatment options for your patient.


“Genomenon’s essential role in curating actionable genomic information and making it easily accessible from the Mastermind knowledgebase is critical to making newborn screening for a broad set of rare diseases a reality.”
Efficiently manage and analyze large volumes of genomic information with automated workflows for data analysis, variant calling, interpretation and identification of relevant clinical trials.
- Reduce turnaround times and enhance overall diagnostic efficiency
- Streamline workflows by rapidly triaging variants to focus on known disease-causing gene, and query and access updated evidence- based information on therapeutic interventions


"We looked for the best tools to accelerate literature curation and found there is no comparable solution in the market like Mastermind."
Empower your variant interpretation team to be even more efficient through our rapid on-demand evidence curation and variant classification services.
- Increase efficiencies that lower costs and decrease turnaround time
- Focus on faster patient diagnosis and improved treatment outcomes
- Access high-value, cost-effective solutions that enhance lab efficiency and productivity


“I feel like my curation work will actively make a difference in patients with genetic disease.”
Impacting Top Research Institutions and Hospitals
Trusted by Industry Leaders Including















Our Offerings for Clinical
Talk to a Genomenon expert.
